Atoltivimab
Generic Name: atoltivimab
Dosage form: INJECTION, SOLUTION. Active ingredients: ATOLTIVIMAB (100 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION, SOLUTION. Active ingredients: ATOLTIVIMAB (100 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection, solution.
Related Medications
Valine, Lysine, Histidine, Isoleucine, Leucine, Phenylalanine, Threonine, Methionine, Tryptophan, Alanine, Glycine, Arginine, Proline, Glutamic Acid, Serine, Aspartic Acid And Tyrosine
valine, lysine, histidine, isoleucine, leucine, phenylalanine, threonine, methionine, tryptophan, alanine, glycine, arginine, proline, glutamic acid, serine, aspartic acid and tyrosine
Amino Acid [EPC]
11 DESCRIPTION PROSOL 20% (amino acids) injection is a sterile, nonpyrogenic, hypertonic solution of essential and nonessential amino acids supplied in a flexible container as a Pharmacy Bulk Package. A Pharmacy Bulk Package is a container of a sterile preparation for parenteral use that contains many single doses. The contents are intended for use in a pharmacy admixture program [see Dosage and Administration (2.1) ]. PROSOL is not for direct intravenous infusion.
Desvenlafaxine Fumarate
desvenlafaxine fumarate
Manufactured by TEVA PHARMS USA. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DESVENLAFAXINE FUMARATE (EQ 100MG BASE). Application: NDA205208.
Sacituzumab Govitecan
sacituzumab govitecan
11 DESCRIPTION Sacituzumab govitecan-hziy is a Trop-2 directed antibody and topoisomerase inhibitor conjugate, composed of the following three components: the humanized monoclonal antibody, hRS7 IgG1κ (also called sacituzumab), which binds to Trop-2 (the trophoblast cell-surface antigen-2); the drug SN-38, a topoisomerase inhibitor; a hydrolysable linker (called CL2A), which links the humanized monoclonal antibody to SN-38.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.